Literature DB >> 13641406

Studies on the circulating insulin inhibitor found in some diabetic patients exhibiting chronic insulin resistance.

J B FIELD.   

Abstract

Entities:  

Keywords:  DIABETES MELLITUS/blood in; INSULIN/antagonists

Mesh：

Substances：

Year:  1959        PMID： 13641406      PMCID： PMC293191          DOI： 10.1172/JCI103833

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  21 in total

1.  Localization of an insulin-neutralizing factor by zone electrophoresis in a serum of an insulin-resistant patient.

Authors:  A H SEHON; M KAYE; E McGARRY; B ROSE
Journal:  J Lab Clin Med       Date:  1955-05

2.  Evidence for the insulin-directed specificity of rabbit anti-insulin serum.

Authors:  E R ARQUILLA; A B STAVITSKY
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

3.  The production and identification of antibodies to insulin and their use in assaying insulin.

Authors:  E R ARQUILLA; A B STAVITSKY
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

4.  A case of insulin resistance treated with corticotropin.

Authors:  J KLEEBERG; D DIENGOTT; J GOTTFRIED
Journal:  J Clin Endocrinol Metab       Date:  1956-05       Impact factor: 5.958

5.  Physical binding of insulin by gamma globulins of insulin-resistant subjects.

Authors:  B A BURROWS; T PETERS; F C LOWELL
Journal:  J Clin Invest       Date:  1957-03       Impact factor: 14.808

6.  Studies with insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  Diabetes       Date:  1957 Sep-Oct       Impact factor: 9.461

7.  Humoral insulin antagonism associated with diabetic acidosis.

Authors:  J B FIELD; D STETTEN
Journal:  Am J Med       Date:  1956-09       Impact factor: 4.965

8.  Estimation of plasma-insulin by the rat diaphragm method.

Authors:  J VALLANCE-OWEN; B HURLOCK
Journal:  Lancet       Date:  1954-01-09       Impact factor: 79.321

9.  The effect of serum from insulin-resistant cases on the combination of insulin with the rat diaphragm.

Authors:  J B MARSH; N HAUGAARD
Journal:  J Clin Invest       Date:  1952-01       Impact factor: 14.808

10.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808
View more
  9 in total

1.  EFFECT OF CIRCULATING ANTIBODY TO INSULIN ON SERUM LEVELS OF INSULIN-LIKE ACTIVITY IN RATS, GUINEA-PIGS, AND A DIABETIC PATIENT.

Authors:  N SAMAAN; R FRASER
Journal:  Br Med J       Date:  1964-08-22

2.  [New observations on the treatment of chronic insulin resistance and experimental research on its genesis].

Authors:  H DAWEKE; I BACH
Journal:  Klin Wochenschr       Date:  1963-03-15

3.  An immunochemical assay of total extractable insulin in man.

Authors:  G M GRODSKY; P H FORSHAM
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

4.  Unusual insulin requirements in a patient with diabetic acidosis during and after pregnancy.

Authors:  H C KNOWLES; W R TUCKER; J L BRAMSCHREIBER; E ZALME
Journal:  Trans Am Clin Climatol Assoc       Date:  1961

5.  Cyclophosphamide inhibition of insulin antibody production, insulin resistance and experimental immunodiabetes.

Authors:  L Korcáková; M Titlbach; K Nouza
Journal:  Acta Diabetol Lat       Date:  1972 Nov-Dec

Review 6.  [Chronic insulin resistance].

Authors:  J B Field
Journal:  Acta Diabetol Lat       Date:  1970 Mar-Apr

7.  [Study of anti-insulin antibodies of human serum in normal and diabetic subjects].

Authors:  A Ghidoni; G Sorgato; E Sanesi; G Pozza
Journal:  Acta Diabetol Lat       Date:  1968 Apr-Jun

8.  Insulin resistant diabetes mellitus in association with haemochromatosis.

Authors:  I D Heath
Journal:  Postgrad Med J       Date:  1965-09       Impact factor: 2.401

9.  Insulin-resistant diabetes associated with increased endogenous plasma insulin followed by complete remission.

Authors:  J B FIELD; P JOHNSON; B HERRING
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.